Erdheim–Chester disease with cardiac involvement confirmed by biopsy: a case report
This case report details a 44-year-old woman with Erdheim–Chester disease and cardiac involvement, whose diagnosis was confirmed through open cardiac biopsy and genetic testing, highlighting the critical role of histopathological verification in this rare condition to improve clinical recognition and reduce misdiagnosis.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Some illnesses hide in plain sight, masquerading as common ailments until they reveal a far more complex nature. One such condition is Erdheim–Chester disease, a rare disorder where the body's immune system goes into overdrive, producing an excess of a specific type of cell called a histiocyte. Normally, these cells help clean up debris and fight infection, but in this disease, they multiply uncontrollably and invade various organs, including the bones, lungs, and heart. Because the symptoms can vary wildly from person to person, ranging from simple bone pain to life-threatening heart complications, doctors often struggle to identify the disease early. The stakes are high, particularly when the heart is involved, as this can lead to severe failure. Without a clear way to distinguish this rare condition from other causes of heart masses, patients may receive the wrong treatment or none at all.
A recent case report from a hospital in China highlights the difficulty of solving this medical puzzle and the critical steps required to find the answer. The story centers on a forty-four-year-old woman who had been suffering from recurring fevers and abdominal pain for six months. She had a history of kidney cancer, which initially led doctors to worry about a return of the disease or a new infection. Early scans of her abdomen showed inflammation, and a small tissue sample taken from her belly suggested a non-specific inflammatory condition, leading to a temporary improvement with standard treatment. However, her fever returned with a vengeance, reaching nearly 39.3 degrees Celsius, and new scans revealed a troubling development: a growing mass of soft tissue surrounding the right side of her heart, accompanied by fluid buildup around the organ.
The medical team faced a difficult dilemma. The images showed a mass that looked suspiciously like a tumor or a lymphoma, but they could not be certain. Standard imaging techniques, such as the PET-CT scan used to track the disease's activity, showed that the tissue was highly active metabolically, a trait shared by both cancerous tumors and this rare inflammatory disease. Because the treatment for a heart tumor is vastly different from the treatment for an inflammatory condition, guessing was not an option. The team decided that the only way to know for sure was to look directly at the tissue under a microscope. They performed an open-heart surgery to take a biopsy of the mass on the right side of her heart.
The results of this direct examination provided the clarity the doctors needed. The tissue was not cancer. Instead, it was filled with the same foamy, lipid-laden cells characteristic of Erdheim–Chester disease. Further genetic testing on the sample revealed a specific mutation in a gene called MAP2K1, while ruling out another common mutation often seen in similar diseases. To confirm the diagnosis, the team also checked her bones, where the disease frequently leaves its mark. A bone scan showed increased activity in her lower legs, a classic sign of the condition. With the diagnosis confirmed, the patient was moved to a specialized unit and began treatment with a medication called interferon-alpha.
This case serves as a vital reminder of the importance of looking beyond the surface when standard tests fail to provide answers. While many reports of heart involvement in this disease rely only on pictures from scans, this report documents a rare instance where a physical tissue sample from the heart itself confirmed the diagnosis. The patient is currently undergoing treatment, and follow-up assessments indicate that the cardiac pseudotumor has shrunk compared to previous images, with no significant progression of the disease. By sharing this detailed journey from confusion to clarity, the authors hope to help other doctors recognize the signs of this rare disease sooner, ensuring that patients with unexplained heart masses and fever receive the correct care before the condition causes irreversible damage.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.